Bionano Genomics (BNGO) Non-Current Assets (2017 - 2026)
Bionano Genomics (BNGO) posted Non-Current Assets of $25.8 million for Q1 2026, down 8.4% sequentially from $28.2 million in Q4 2025, and down 22.86% YoY from $33.5 million in Q1 2025.
Bionano Genomics (BNGO) Non-Current Assets (2017 - 2026) Analysis & Trends
Bionano Genomics has reported Non-Current Assets for 10 years, with the latest figure at $25.8 million in Q1 2026.
- Quarterly Non-Current Assets fell 22.86% year-over-year to $25.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $117.6 million (down 34.59% YoY) and the FY2025 annual result came in at $28.2 million, down 24.16% from the prior year.
- Non-Current Assets declined to $25.8 million in Q1 2026 per BNGO's latest filing, from $28.2 million in the prior quarter.
- Over five years, Non-Current Assets peaked at $150.2 million in Q4 2022 and troughed at $25.8 million in Q1 2026.
- A 5-year average of $75.7 million and a median of $72.4 million in 2024 frame the typical range for Non-Current Assets.
- The sharpest annual moves came in 2022 and 2024: Non-Current Assets jumped 624.51% in 2022, then slumped 53.77% in 2024.
- Over 5 years, Non-Current Assets stood at $150.2 million in 2022, then tumbled by 50.54% to $74.3 million in 2023, then sank by 49.95% to $37.2 million in 2024, then slipped by 24.16% to $28.2 million in 2025, then declined by 8.4% to $25.8 million in 2026.
- According to Business Quant data, Non-Current Assets over the past three periods registered $25.8 million, $28.2 million, and $30.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.89 Bn | 129.68 Bn | 1.96 Bn | 11.33 Bn |
| 2 | Becton Dickinson | 52.60 Bn | 51.73 Bn | 2.32 Bn | 42.59 Bn |
| 3 | Alcon | 35.78 Bn | 34.42 Bn | 1.68 Bn | 24.47 Bn |
| 4 | Resmed | 33.93 Bn | 32.46 Bn | 861.22 Mn | 4.64 Bn |
| 5 | Medline | 29.16 Bn | 26.49 Bn | 2.22 Bn | 27.61 Bn |
| 6 | West Pharmaceutical Services | 24.87 Bn | 24.43 Bn | 329.20 Mn | 2.27 Bn |
| 7 | Solventum | 15.40 Bn | 15.00 Bn | 1.29 Bn | 10.50 Bn |
| 8 | Cooper Companies | 14.85 Bn | 14.72 Bn | 735.40 Mn | 10.18 Bn |
| 9 | Baxter International | 13.62 Bn | 11.47 Bn | 1.03 Bn | 12.80 Bn |
| 10 | Bionano Genomics | 14.49 Mn | 4.56 Mn | 4.31 Mn | 22.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 22.71 Mn |
| Mar 31, 2026 | 25.83 Mn |
| Dec 31, 2025 | 28.20 Mn |
| Sep 30, 2025 | 30.26 Mn |
| Jun 30, 2025 | 33.35 Mn |
| Mar 31, 2025 | 33.49 Mn |
| Dec 31, 2024 | 37.18 Mn |
| Sep 30, 2024 | 40.38 Mn |
| Jun 30, 2024 | 68.80 Mn |
| Mar 31, 2024 | 72.38 Mn |
| Dec 31, 2023 | 74.29 Mn |
| Sep 30, 2023 | 77.37 Mn |
| Jun 30, 2023 | 148.81 Mn |
| Mar 31, 2023 | 149.59 Mn |
| Dec 31, 2022 | 150.20 Mn |
| Sep 30, 2022 | 105.50 Mn |
| Jun 30, 2022 | 105.26 Mn |
| Mar 31, 2022 | 105.85 Mn |
| Dec 31, 2021 | 104.69 Mn |
| Sep 30, 2021 | 17.61 Mn |